Increased extra domain-A containing fibronectin and hepatic dysfunction during septic response: An in vivo and in vitro study

Shock

Volumn 13, Issue 6, 2000, Pages 492-496

  Satoi, Sohei ^a   Kitade, Hiroaki ^a   Hiramatsu, Yoshifumi ^a   Kwon, A Hon ^a   Takahashi, Hakuo ^a   Sekiguchi, Kiyotoshi ^b   Uehara, Masanori ^a   Oda, Michio ^a   Yanagimoto, Yasuaki ^a   Miyashita, Keiichi ^c   Sakashita, Eiji ^c   Kamiyama, Yasuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Culture; Cytokine; Fibroblast; Hepatocyte; Interleukin 1; Interleukin 6; Sepsis; Tumor necrosis factor

Indexed keywords

BIOLOGICAL MARKER; FIBRONECTIN; HYBRID PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; ISOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMEN; AGED; APACHE; ARTICLE; BLOOD; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENETICS; HUMAN; LIVER; LIVER FUNCTION TEST; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATION; PROTEIN TERTIARY STRUCTURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ABDOMEN; AGED; APACHE; BIOLOGICAL MARKERS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; FIBRONECTINS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATIONS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034203548     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200006000-00012     Document Type: Article

References (28)

1. Ruoslahti E, Engvall E, Hayman EG: Fibronectin: current concepts of its structure and function. Coll Relat Res 1:95-128, 1981.
2. Colvin RB: Fibronectin in wound healing. In: Mosher DF (ed): Fibronectin. San Diego, Academic, 1989, pp 213-254.
3. McKeown-Longo PJ, Mosher DF: Mechanism of formation of disulfide-bonded multimers of plasma fibronectin in cell layers of cultured human fibroblasts. J Biol Chem 259:12210-12215, 1984.
4. Yamada KM: Fibronectin and other cell interactive glycoproteins. In: Hay ED (ed): Cell Biology of Extracellular Matrix. San Diego, Academic Press, 1991, pp 111-146.
5. Hynes RO: Fibronectins. New York, Springer-Verlag, 1990.
6. Tamkun JW, Hynes RO: Plasma fibronectin is synthesized and secreted by hepatocytes. J Biol Chem 258:4641-4647, 1983.
7. Vartio T, Laitenen L, Narvanen O, et al: Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissue. J Cell Sci 88:419-430, 1987.
8. Peters JH, Maunder RJ, Woolf AD, et al: Elevated plasma levels of ED1+ (cellular) fibronectin in patients with vascular injury. J Lab Clin Med 113:586-597, 1989.
9. Rizk TA, Rebres RA, Vincent PA, et al: Delayed elevation of ED1-cellular fibronectin in plasma following postsurgical bacteremia. Am J Physiol 266:689-697, 1994.
10. Lockwood CJ, Senyei AE, Dische R, et al: Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325:669-674.
11. Ylatupa S, Haglund C, Mertaniemi P, et al: Cellular fibronectin in serum and plasma: a potential new tumor marker? Br J Cancer 71:578-582, 1995.
12. Korner T, Kropf J, Hackler R, et al: Fibronectin in human bile fluid for diagnosis of malignant biliary diseases. Hepatology 23:423-428, 1996.
13. Satoi S, Hiramatsu Y, Kitade H, et al: Differing response to surgical stress between extra domain-A+ and plasma fibronectins. Clin Exp Pharmacol Physiol 26:225-229, 1999.
14. 2 in a primary culture of adult rat hepatocytes. J Biochem Tokyo 96:429-436, 1984.
15. Horiuti Y, Ogishima M, Yano K, Shibuya Y: Quantification of cell nuclei isolated from hepatocytes by cell lysis with nonionic detergent in citric acid. Cell Struct Funct 16:203-207, 1991.
16. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American college of chest physicians/socity of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
17. Hirano H, Tachikawa T, Hino K, et al: Development of enzyme-linked immunosorbent assay (ELISA) for the detection of cellular type fibronectin by EDA-region specific monoclonal antibody (in Japanese). J Clin Lab Instrum Reagents 15:179-184, 1992.
18. Hino K, Shiozawa S, Kuroki Y, et al: EDA-containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells. Arthritis Rheum 38:678-683, 1995.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE?: a severity of disease classification system. Crit Care Med 13:818-829, 1985.
20. Schwarzbauer JE: Fibronectin; from gene to protein. Curr Opin Cell Biol 3:781-786, 1991.
21. Kwon A-H, Inada Y, Uetsuji S, et al: Response of fibronectin to liver regeneration after hepatectomy. Hepatology 11:593-598, 1990.
22. Kwon A-H, Uetsuji S, Yamamura M, et al: Effect of administration of fibronectin or aprotinin on liver regeneration after experimental hepatectomy. Ann Surg 211:295-300, 1990.
23. Peters JH, Ginsberg MH, Bohl BP, et al: Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung. J Clin Invest 78:1596-1603, 1986.
24. Rizk T, Rebres R, Vincent P, et al: ED1-containing cellular fibronectin release into lung lymph during lung vascular injury with postoperative bacteremia. Am J Physiol 264:66-73, 1993.
25. Daudi I, Gudewicz PW, Saba TM, et al: Proteolysis of gelatin-bound fibronectin by activated leukocytes: a role of leukocyte elastase. J Leukocyte Biol 50:331-340, 1991.
26. McDonald JA, Kelly DG: Degradation of fibronectin by human leukocyte elastase: release of biologically active fragments. J Biol Chem 255:8848-8858, 1980.
27. Richards PS, Saba TM, Del Vecchio PJ, et al: Matrix fibronectin disruption in association with altered endothelial cell adhesion induced by activated polymorphonuclear leukocytes. Exp Mol Pathol 45:1-21, 1986.
28. Vincent PA, Del Vecchio PJ, Saba TM: Release of fibronectin fragments from endothelial cell monolayers exposed to activated leukocytes: relationship to plasma fibronectin levels after particle infusion. Exp Mol Pathol 48:403-418, 1988.